Healthcare entity
All 1 tracked stories fall under one category: health-it. Kyntra Bio is most often covered alongside Assertio, which appears in 1 of these 1 story. Each story carries 7 original sources on average, compared with 3.1 for the broader beat in this window.
Last mentioned: Mar 17, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: health-it. Kyntra Bio is most often covered alongside Assertio, which appears in 1 of these 1 story. Each story carries 7 original sources on average, compared with 3.1 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Kyntra Bio appears in 1 tracked Healthcare story from March 17, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Kyntra Bio. Shared-story counts are live from our verified record — not editorial picks.
DocGo is successfully transitioning from large-scale government contracts to high-growth remote patient monitoring and mobile health services, while specialty firms like Kyntra Bio and Assertio are streamlining operations to focus on core clinical assets. These shifts reflect a broader industry trend toward sustainable, technology-driven care models and disciplined capital allocation.
Kyntra Bio is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
